Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Byrne

Showing results (21-30 of 458) with videos related to

Pageof 46
Sort By:
Current Opinion in Lipidology|June 24, 2015
Importance of early recognition of heterozygous familial hypercholesterolaemiaAidan Ryan, Christopher D Byrne
Digestive Diseases (Basel, Switzerland)|August 23, 2016
Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and DysbiosisEleonora Scorletti, Christopher D Byrne
European Heart Journal|May 5, 2018
Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart diseaseChristopher D Byrne, Giovanni Targher
Evidence-Based Medicine|June 5, 2010
There is a slight increase in incident diabetes risk with the use of statins, but benefits likely outweigh any adverse effects in those with moderate-to-high cardiovascular riskLokpal Bhatia, Christopher D Byrne
Arteriosclerosis, Thrombosis, and Vascular Biology|April 19, 2014
Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular diseaseChristopher D Byrne, Giovanni Targher
Diabetologia|April 8, 2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?Christopher D Byrne, Giovanni Targher
International Journal of Molecular Sciences|March 16, 2016
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromePatrick Wainwright, Christopher D Byrne
Diabetes, Obesity & Metabolism|July 29, 2021
Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complicationsChristopher D Byrne, Giovanni Targher
The Lancet. Diabetes & Endocrinology|June 6, 2022
How should endocrinologists diagnose and treat non-alcoholic fatty liver disease?Christopher D Byrne, Giovanni Targher
Hepatobiliary Surgery and Nutrition|December 20, 2023
Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older populationJosh Bilson, Christopher D Byrne
Pageof 46

Showing results (21-30 of 458) with videos related to

Sort By:
Pageof 46
Current Opinion in Lipidology|June 24, 2015
Importance of early recognition of heterozygous familial hypercholesterolaemiaAidan Ryan, Christopher D Byrne
Digestive Diseases (Basel, Switzerland)|August 23, 2016
Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and DysbiosisEleonora Scorletti, Christopher D Byrne
European Heart Journal|May 5, 2018
Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart diseaseChristopher D Byrne, Giovanni Targher
Evidence-Based Medicine|June 5, 2010
There is a slight increase in incident diabetes risk with the use of statins, but benefits likely outweigh any adverse effects in those with moderate-to-high cardiovascular riskLokpal Bhatia, Christopher D Byrne
Arteriosclerosis, Thrombosis, and Vascular Biology|April 19, 2014
Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular diseaseChristopher D Byrne, Giovanni Targher
Diabetologia|April 8, 2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?Christopher D Byrne, Giovanni Targher
International Journal of Molecular Sciences|March 16, 2016
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromePatrick Wainwright, Christopher D Byrne
Diabetes, Obesity & Metabolism|July 29, 2021
Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complicationsChristopher D Byrne, Giovanni Targher
The Lancet. Diabetes & Endocrinology|June 6, 2022
How should endocrinologists diagnose and treat non-alcoholic fatty liver disease?Christopher D Byrne, Giovanni Targher
Hepatobiliary Surgery and Nutrition|December 20, 2023
Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older populationJosh Bilson, Christopher D Byrne
Pageof 46